Jet nebulisation

Influence of dynamic conditions and nebuliser on nebulisation duality. Application to the α1 protease inhibitor

M. P. Flament, P. Leterme, T. Burnouf, A. T. Gayot

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The use of nebulisers lacks standardisation, which may account for certain inefficiency. As part of a study of α 1 protease inhibitor (α1 PI) nebulisation for pulmonary administration, we studied the influence of technological parameters that is to say the nebuliser and the dynamic conditions (airflow and pressure) on nebulisation quality. The quality of nebulisation is evaluated by measurement of the percentage of droplets below 5.79 μm, the quantity of α1 PI nebulised, the quantity of α1 PI likely to reach the lungs and nebulisation time. The use of different dynamic conditions results in variable nebulisation quality. Depending upon the power of the compressor and the type of nebuliser, drug delivery varies. The association of high airflow and high pressure improves the respirable fraction and compliance by decreasing nebulisation time. Although droplet size is a commonly used parameter, it is not sufficient to forecast efficiency. It must be associated with the quantity of drug nebulised and, to a lesser extent, nebulisation time. The nebuliser is also to be taken into consideration. The characteristics of the constituent nebuliser elements, that is to say liquid and air tube orifices, size and shape of the reservoir, shape and position of the impartion system, are preponderant on nebulisation quality.

Original languageEnglish
Pages (from-to)93-101
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume148
Issue number1
DOIs
Publication statusPublished - Mar 14 1997
Externally publishedYes

Fingerprint

Nebulizers and Vaporizers
Protease Inhibitors
Pressure
Lung
Pharmaceutical Preparations
Compliance
Air

Keywords

  • α1 Protease inhibitor
  • Droplet size
  • Dynamic conditions
  • Nebulisation time
  • Nebuliser
  • Quantity of drug nebulised

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Jet nebulisation : Influence of dynamic conditions and nebuliser on nebulisation duality. Application to the α1 protease inhibitor. / Flament, M. P.; Leterme, P.; Burnouf, T.; Gayot, A. T.

In: International Journal of Pharmaceutics, Vol. 148, No. 1, 14.03.1997, p. 93-101.

Research output: Contribution to journalArticle

@article{54d784c3660e44e4b84c95743086366a,
title = "Jet nebulisation: Influence of dynamic conditions and nebuliser on nebulisation duality. Application to the α1 protease inhibitor",
abstract = "The use of nebulisers lacks standardisation, which may account for certain inefficiency. As part of a study of α 1 protease inhibitor (α1 PI) nebulisation for pulmonary administration, we studied the influence of technological parameters that is to say the nebuliser and the dynamic conditions (airflow and pressure) on nebulisation quality. The quality of nebulisation is evaluated by measurement of the percentage of droplets below 5.79 μm, the quantity of α1 PI nebulised, the quantity of α1 PI likely to reach the lungs and nebulisation time. The use of different dynamic conditions results in variable nebulisation quality. Depending upon the power of the compressor and the type of nebuliser, drug delivery varies. The association of high airflow and high pressure improves the respirable fraction and compliance by decreasing nebulisation time. Although droplet size is a commonly used parameter, it is not sufficient to forecast efficiency. It must be associated with the quantity of drug nebulised and, to a lesser extent, nebulisation time. The nebuliser is also to be taken into consideration. The characteristics of the constituent nebuliser elements, that is to say liquid and air tube orifices, size and shape of the reservoir, shape and position of the impartion system, are preponderant on nebulisation quality.",
keywords = "α1 Protease inhibitor, Droplet size, Dynamic conditions, Nebulisation time, Nebuliser, Quantity of drug nebulised",
author = "Flament, {M. P.} and P. Leterme and T. Burnouf and Gayot, {A. T.}",
year = "1997",
month = "3",
day = "14",
doi = "10.1016/S0378-5173(96)04836-3",
language = "English",
volume = "148",
pages = "93--101",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Jet nebulisation

T2 - Influence of dynamic conditions and nebuliser on nebulisation duality. Application to the α1 protease inhibitor

AU - Flament, M. P.

AU - Leterme, P.

AU - Burnouf, T.

AU - Gayot, A. T.

PY - 1997/3/14

Y1 - 1997/3/14

N2 - The use of nebulisers lacks standardisation, which may account for certain inefficiency. As part of a study of α 1 protease inhibitor (α1 PI) nebulisation for pulmonary administration, we studied the influence of technological parameters that is to say the nebuliser and the dynamic conditions (airflow and pressure) on nebulisation quality. The quality of nebulisation is evaluated by measurement of the percentage of droplets below 5.79 μm, the quantity of α1 PI nebulised, the quantity of α1 PI likely to reach the lungs and nebulisation time. The use of different dynamic conditions results in variable nebulisation quality. Depending upon the power of the compressor and the type of nebuliser, drug delivery varies. The association of high airflow and high pressure improves the respirable fraction and compliance by decreasing nebulisation time. Although droplet size is a commonly used parameter, it is not sufficient to forecast efficiency. It must be associated with the quantity of drug nebulised and, to a lesser extent, nebulisation time. The nebuliser is also to be taken into consideration. The characteristics of the constituent nebuliser elements, that is to say liquid and air tube orifices, size and shape of the reservoir, shape and position of the impartion system, are preponderant on nebulisation quality.

AB - The use of nebulisers lacks standardisation, which may account for certain inefficiency. As part of a study of α 1 protease inhibitor (α1 PI) nebulisation for pulmonary administration, we studied the influence of technological parameters that is to say the nebuliser and the dynamic conditions (airflow and pressure) on nebulisation quality. The quality of nebulisation is evaluated by measurement of the percentage of droplets below 5.79 μm, the quantity of α1 PI nebulised, the quantity of α1 PI likely to reach the lungs and nebulisation time. The use of different dynamic conditions results in variable nebulisation quality. Depending upon the power of the compressor and the type of nebuliser, drug delivery varies. The association of high airflow and high pressure improves the respirable fraction and compliance by decreasing nebulisation time. Although droplet size is a commonly used parameter, it is not sufficient to forecast efficiency. It must be associated with the quantity of drug nebulised and, to a lesser extent, nebulisation time. The nebuliser is also to be taken into consideration. The characteristics of the constituent nebuliser elements, that is to say liquid and air tube orifices, size and shape of the reservoir, shape and position of the impartion system, are preponderant on nebulisation quality.

KW - α1 Protease inhibitor

KW - Droplet size

KW - Dynamic conditions

KW - Nebulisation time

KW - Nebuliser

KW - Quantity of drug nebulised

UR - http://www.scopus.com/inward/record.url?scp=0030982863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030982863&partnerID=8YFLogxK

U2 - 10.1016/S0378-5173(96)04836-3

DO - 10.1016/S0378-5173(96)04836-3

M3 - Article

VL - 148

SP - 93

EP - 101

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -